Who
Joseph Lacob
Director
Company insider
Files Form 4 as: Director, Align Technology; Director, Neuropace; Director and 10% owner, Orexigen Therapeutics; Director and 10% owner, eHealth.
In numbers
- Trades disclosed
- 221
- Buys
- 0
- Sells
- 35
- Bought
- $0
- Sold
- $101.9M
- Companies
- 4
- Companies where not an officer
- 4
- First trade
- 24 May 2006
- Last trade
- 20 May 2026
- Last filed
- 22 May 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 20 May 2026filed 22 May 2026 | ALGN Align TechnologyMedical Devices | SEC FORM 4 Code M | —1,745 at $0.00 | filing |
| 20 May 2026filed 22 May 2026 | ALGN Align Technologyoption or derivative · Medical Devices | SEC FORM 4 Code M | —1,745 at $0.00 | filing |
| 20 May 2026filed 22 May 2026 | ALGN Align Technologyoption or derivative · Medical Devices | SEC FORM 4 Code A | —1,836 at $0.00 | filing |
| 20 May 2026filed 22 May 2026 | ALGN Align Technologyoption or derivative · Medical Devices | SEC FORM 4 Code M | —1,745 at $0.00 | filing |
| 20 May 2026filed 22 May 2026 | ALGN Align Technologyoption or derivative · Medical Devices | SEC FORM 4 Code A | —1,836 at $0.00 | filing |
| 20 May 2026filed 22 May 2026 | ALGN Align TechnologyMedical Devices | SEC FORM 4 Code M | —1,745 at $0.00 | filing |
| 20 Mar 2026filed 24 Mar 2026 | NPCE NeuropaceMedical Devices | SEC FORM 4 Code A | $11K865 at $13.00 | filing |
| 20 Mar 2026filed 24 Mar 2026 | NPCE NeuropaceMedical Devices | SEC FORM 4 Code A | $11K865 at $13.00 | filing |
| 19 Dec 2025filed 23 Dec 2025 | NPCE NeuropaceMedical Devices | SEC FORM 4 Code A | $11K678 at $16.59 | filing |
| 19 Sep 2025filed 22 Sep 2025 | NPCE NeuropaceMedical Devices | SEC FORM 4 Code A | $11K1,131 at $9.94 | filing |
| 21 Jun 2025filed 24 Jun 2025 | NPCE NeuropaceMedical Devices | SEC FORM 4 Code A | $11K1,080 at $10.41 | filing |
| 6 Jun 2025filed 9 Jun 2025 | NPCE Neuropaceoption or derivative · Medical Devices | SEC FORM 4 Code A | —8,745 at $0.00 | filing |
| 21 May 2025filed 22 May 2025 | ALGN Align Technologyoption or derivative · Medical Devices | SEC FORM 4 Code M | —1,148 at $0.00 | filing |
| 21 May 2025filed 22 May 2025 | ALGN Align Technologyoption or derivative · Medical Devices | SEC FORM 4 Code A | —1,745 at $0.00 | filing |
| 21 May 2025filed 22 May 2025 | ALGN Align TechnologyMedical Devices | SEC FORM 4 Code M | —1,148 at $0.00 | filing |
| 21 Mar 2025filed 24 Jun 2025 | NPCE NeuropaceMedical Devices | SEC FORM 4 Code A | $11K935 at $12.02 | filing |
| 21 Dec 2024filed 24 Jun 2025 | NPCE NeuropaceMedical Devices | SEC FORM 4 Code A | $11K975 at $11.53 | filing |
| 30 Sep 2024filed 24 Jun 2025 | NPCE NeuropaceMedical Devices | SEC FORM 4 Code A | $11K1,614 at $6.97 | filing |
| 28 Jun 2024filed 24 Jun 2025 | NPCE NeuropaceMedical Devices | SEC FORM 4 Code A | $11K1,488 at $7.56 | filing |
| 7 Jun 2024filed 11 Jun 2024 | NPCE Neuropaceoption or derivative · Medical Devices | SEC FORM 4 Code A | —17,774 at $0.00 | filing |
News
Align Technology Wins UPC Patent Case Against AngelalignALGN · rttnews.com · 17 Oct 2026
0 headlines in the last 90 days name Joseph Lacob; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.